LOS ANGELES CAPITAL MANAGEMENT LLC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$525,085
-34.6%
135,681
+0.8%
0.00%
-33.3%
Q2 2023$802,442
+77.4%
134,638
-2.7%
0.00%
+50.0%
Q1 2023$452,365
-19.0%
138,338
-2.1%
0.00%
-33.3%
Q4 2022$558,210
-34.2%
141,3190.0%0.00%
-25.0%
Q3 2022$848,000
-16.3%
141,319
-10.3%
0.00%
-20.0%
Q2 2022$1,013,000
-59.8%
157,489
-48.3%
0.01%
-50.0%
Q1 2022$2,517,000304,6660.01%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders